Lower dose, fewer side effects: pill cuts breast cancer return by 42%
NCT ID NCT06982313
Summary
This study followed women for nearly 10 years to see if a lower dose of the drug tamoxifen could safely prevent breast cancer from coming back. It involved over 500 women who had a type of early, non-invasive breast cancer or high-risk breast lesions. The results showed the lower dose significantly reduced the risk of new or recurring breast cancer, especially in the opposite breast, without increasing serious side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER INVASIVE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Study site
Genova, Italy, 16145, Italy
-
E. O. Ospedali Galliera
Genoa, Italy
Conditions
Explore the condition pages connected to this study.